Citigroup Inc Nevro Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Nevro Corp stock. As of the latest transaction made, Citigroup Inc holds 27,944 shares of NVRO stock, worth $126,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,944

Previous 11,465 143.73%

Holding current value

$126,306

Previous $96,000 61.46%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.71 - $10.1 $77,616 - $166,437	16,479 Added 143.73%	27,944 $155,000
Q2 2024 Aug 12, 2024	SELL	$7.96 - $13.59 $54,406 - $92,887	-6,835 Reduced 37.35%	11,465 $96,000
Q1 2024 May 10, 2024	BUY	$13.56 - $20.78 $179,547 - $275,147	13,241 Added 261.73%	18,300 $264,000
Q4 2023 Feb 09, 2024	BUY	$14.18 - $22.31 $52,763 - $83,015	3,721 Added 278.1%	5,059 $108,000
Q3 2023 Nov 09, 2023	SELL	$18.22 - $25.85 $206,450 - $292,906	-11,331 Reduced 89.44%	1,338 $25,000
Q2 2023 Aug 10, 2023	BUY	$22.62 - $39.32 $239,229 - $415,848	10,576 Added 505.3%	12,669 $322,000
Q1 2023 May 11, 2023	SELL	$30.17 - $41.11 $362,733 - $494,265	-12,023 Reduced 85.17%	2,093 $75,000
Q4 2022 Feb 09, 2023	BUY	$36.43 - $49.4 $411,731 - $558,318	11,302 Added 401.63%	14,116 $558,000
Q3 2022 Nov 10, 2022	SELL	$40.66 - $53.03 $83,678 - $109,135	-2,058 Reduced 42.24%	2,814 $132,000
Q2 2022 Aug 10, 2022	BUY	$40.85 - $77.67 $103,309 - $196,427	2,529 Added 107.94%	4,872 $214,000
Q1 2022 May 12, 2022	SELL	$59.95 - $92.06 $438,534 - $673,418	-7,315 Reduced 75.74%	2,343 $170,000
Q4 2021 Feb 10, 2022	BUY	$81.07 - $121.29 $414,105 - $619,549	5,108 Added 112.26%	9,658 $783,000
Q3 2021 Nov 10, 2021	BUY	$101.99 - $166.36 $464,054 - $756,938	4,550 New	4,550 $530,000

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account